2026-04-13T01:04:49Zhttps://recercat.cat/oai/request

oai:recercat.cat:2445/1752942025-11-19T10:41:16Zcom_2072_1057col_2072_478815col_2072_478916col_2072_478917

00925njm 22002777a 4500 dc Esteve Pitarch, Erika author Padullés Zamora, Ariadna author Maisterra-Santos, Kristel author Colom Codina, Helena author Cobo Sacristán, Sara author 2021-03-18T09:33:27Z 2021-03-18T09:33:27Z 2019 2021-03-18T09:33:27Z Objective: To determine the percentage of patients given standard doses of piperacillin/tazobactam or meropenem by continuous infusion who achieved the target pharmacokinetic/pharmacodynamic (PK/PD) index, which was defined as free concentrations four times more than the minimum inhibitory KEYWORDS Beta-lactams; Critical care; Pharmacokinetics; Drug monitoring; Piperacillin; Meropenem. Antibiòtics betalactàmics Medicina intensiva Farmacocinètica Beta lactam antibiotics Critical care medicine Pharmacokinetics OTAC: Optimization of Antibiotic Therapy in Critically ill Patients. Using beta-lactam antibiotics by continuous infusion